Effectiveness and safety of first-line tenofovir + emtricitabine + efavirenz for patients with HIV

Simple item page
dc.contributor.authorOmeje I
dc.contributor.authorOkwundu CI
dc.date.accessioned2013-07-03T08:19:34Z
dc.date.available2013-07-03T08:19:34Z
dc.date.issued2012
dc.descriptionGeneeskunde en Gesondheidswetenskappe
dc.descriptionSentrum vir Bewysgebaseerde Gesonheidsorg
dc.descriptionPlease help us populate SUNScholar with the post print version of this article. It can be e-mailed to: scholar@sun.ac.za
dc.identifier.citationCochrane Database of Systematic Reviews
dc.identifier.urihttp://hdl.handle.net/10019.1/82407
dc.publisherJohn Wiley & Sons
dc.titleEffectiveness and safety of first-line tenofovir + emtricitabine + efavirenz for patients with HIV
dc.typeJournal Articles (subsidised)
Files
Collections
2012 - Research Outputs